Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Digestive & Liver Disease Specialists, A Medical Group, Inc.
mi
from
Anaheim, CA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Austin Center for Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
NY Scientific
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
East Valley Gastroenterology and Hepatology
mi
from
Chandler, AZ
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Partners in Clinical Research, LLC
mi
from
Cumberland, RI
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Pharmakon Inc.
mi
from
Evergreen Park, IL
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Clinical Research Advantage
mi
from
Henderson, NV
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
KAMP Medical Research
mi
from
Natchitoches, LA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Health Research of Hampton Roads
mi
from
Newport News, VA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
COR Clinical Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Advanced Gastroenterology Associates, LLC
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Clinical Research Advantage, Inc. / Central Phoenix Medical Clinic, LLC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Sun Research Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Coastal Research Associates
mi
from
Weymouth, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling, Phase I, II
Updated: 12/31/1969
USC Norris Oncology/Hematology-Newport Beach
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
Status: Enrolling, Phase II
Updated: 3/6/2018
Yale School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
Status: Enrolling, Phase II
Updated: 3/6/2018
Florida Hospital Cancer Institute
mi
from
Orlando, FL
Click here to add this to my saved trials
Contraception Clinical Trial
BLIS - Breastfeeding Levonorgestrel IUD Study
Status: Enrolling, Phase IV
Updated: 2/18/2016
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Gastrointestinal Stromal Tumor (GIST) Clinical Trial
MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Blood Loss Clinical Trial
Butterfly Sensor With Rev K Version
Status: Enrolling, Phase IV
Updated: 7/1/2014
University of California - San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Abdominal Aortic Aneurysm (AAA) Clinical Trial
Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
Status: Enrolling
Updated: 8/1/2016
St Elizabeth's Medical Center
mi
from
Brighton, MA
Click here to add this to my saved trials
Abdominal Aortic Aneurysm (AAA) Clinical Trial
Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
Status: Enrolling
Updated: 8/1/2016
St. Vincent Heart Center of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Abdominal Aortic Aneurysm (AAA) Clinical Trial
Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
Status: Enrolling
Updated: 8/1/2016
UPMC Heart and Vascular Institue
mi
from
Pittsburg, PA
Click here to add this to my saved trials
Abdominal Aortic Aneurysm (AAA) Clinical Trial
Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
Status: Enrolling
Updated: 8/1/2016
Tucson Medical Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Patient Derived Breast Cancer Xenografts
Status: Enrolling
Updated: 12/18/2013
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling, Phase III
Updated: 12/12/2013
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling, Phase III
Updated: 12/12/2013
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling, Phase III
Updated: 12/12/2013
Maine Research Associates
mi
from
Auburn, ME
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling, Phase III
Updated: 12/12/2013
Dayton VA Medical Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling, Phase III
Updated: 12/12/2013
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling, Phase III
Updated: 12/12/2013
Allianz Medical and Research Center
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling, Phase III
Updated: 12/12/2013
LeBauer Cardiovascular Research Foundation
mi
from
Greensboro, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling, Phase III
Updated: 12/12/2013
Michael E. Debakey VA Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling, Phase III
Updated: 12/12/2013
Glacier View Research Institute
mi
from
Kalispell, MT
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling, Phase III
Updated: 12/12/2013
St Luke's Health System
mi
from
Kansas City, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling, Phase III
Updated: 12/12/2013
Metropolitan Heart and Vascular Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling, Phase III
Updated: 12/12/2013
Christiana Care Health System
mi
from
Newark, DE
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling, Phase III
Updated: 12/12/2013
Drexel University College of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling, Phase III
Updated: 12/12/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
Status: Enrolling, Phase III
Updated: 12/12/2013
Brevard Cardiovascular Research Associates, Inc
mi
from
Rockledge, FL
Click here to add this to my saved trials
Acute Coronary Syndrome (ACS) Clinical Trial
Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome
Status: Enrolling, Phase IV
Updated: 6/8/2016
University of Florida Health Science Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Diagnosing Adverse Drug Reactions Registry
Status: Enrolling
Updated: 10/7/2014
Lakewood Pediatrics and Family Medicine
mi
from
Durham, NC
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Diagnosing Adverse Drug Reactions Registry
Status: Enrolling
Updated: 10/7/2014
Emporia Medical Associates
mi
from
Emporia, VA
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Diagnosing Adverse Drug Reactions Registry
Status: Enrolling
Updated: 10/7/2014
Gerald Harris MD
mi
from
Glendale, AZ
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Diagnosing Adverse Drug Reactions Registry
Status: Enrolling
Updated: 10/7/2014
Isabel C Vigil MD
mi
from
Las Cruces, NM
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Diagnosing Adverse Drug Reactions Registry
Status: Enrolling
Updated: 10/7/2014
United Medical PC
mi
from
Lyndhurst, NJ
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Diagnosing Adverse Drug Reactions Registry
Status: Enrolling
Updated: 10/7/2014
Ocmulgee Physicians
mi
from
Macon, GA
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Diagnosing Adverse Drug Reactions Registry
Status: Enrolling
Updated: 10/7/2014
Latin Foundation for Health
mi
from
Miami, FL
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Diagnosing Adverse Drug Reactions Registry
Status: Enrolling
Updated: 10/7/2014
Holland Center for Family Health
mi
from
Peoria, AZ
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Diagnosing Adverse Drug Reactions Registry
Status: Enrolling
Updated: 10/7/2014
Stonegate Family Health
mi
from
Reynoldsburg, OH
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Diagnosing Adverse Drug Reactions Registry
Status: Enrolling
Updated: 10/7/2014
Valley Health Care
mi
from
Rome, GA
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Diagnosing Adverse Drug Reactions Registry
Status: Enrolling
Updated: 10/7/2014
Dr. B. Abraham, PC
mi
from
Snellville, GA
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Diagnosing Adverse Drug Reactions Registry
Status: Enrolling
Updated: 10/7/2014
Candler Internal Medicine
mi
from
Statesboro, GA
Click here to add this to my saved trials
Body Contouring Clinical Trial
Evaluation of Procedural Analgesia for Liposonix Treatment
Status: Enrolling
Updated: 11/20/2013
Solta Medical Aesthetic Center
mi
from
Hayward, CA
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Upper Chesapeake Medical Center
mi
from
Bel Air, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Tate Cancer Center
mi
from
Glen Burnie, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
MD Anderson Regional Care Center-Katy
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Pennsylvania:Abramson Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
The Johns Hopkins University School of Medicine Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
Stony Brook Internists PC
mi
from
East Setauket, NY
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
Swedish Cancer Institute Swedish Neuroscience Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
Endocrine Associates of Long Island, PC
mi
from
Smithtown, NY
Click here to add this to my saved trials
Acromegaly Clinical Trial
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Status: Enrolling, Phase IV
Updated: 12/26/2015
Harbor-UCLA Medical Center Center for Men's Health
mi
from
Torrance, CA
Click here to add this to my saved trials
Cerebral Vasospasm Clinical Trial
The Intra-arterial Vasospasm Trial
Status: Enrolling, Phase IV
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hypertension Clinical Trial
The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension
Status: Enrolling, Phase IV
Updated: 12/31/1969
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
3T MRI Biomarkers of Glioma Treatment Response
Status: Enrolling
Updated: 9/1/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Paroxysmal Atrial Fibrillation Clinical Trial
Pilot Study Evaluating the Toray Satake Balloon Thermal Ablation System for Treatment of Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 7/17/2014
Texas Cardiac Arrhythmia Research Foundation
mi
from
Austin, TX
Click here to add this to my saved trials
Orthotopic Liver Transplant Clinical Trial
Everolimus Post Orthotopic Liver Transplant
Status: Enrolling, Phase II
Updated: 8/9/2017
Columbia University Medical Center - NYPH
mi
from
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology, Other Clinical Trial
The Cancer of the Pancreas Screening-5 CAPS5)Study
Status: Enrolling, Phase
Updated: 12/31/1969
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Oncology, Other Clinical Trial
The Cancer of the Pancreas Screening-5 CAPS5)Study
Status: Enrolling, Phase
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Primary Hyperoxaluria Clinical Trial
Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on Dialysis
Status: Enrolling, Phase II
Updated: 3/29/2016
Mayo Clinic - Division of Nephrology
mi
from
Rochester, MN
Click here to add this to my saved trials
Depression Clinical Trial
Neuroimaging Predictors of Antidepressant Treatment Outcome
Status: Enrolling, Phase IV
Updated: 12/16/2013
Department of Psychiatry
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability
Status: Enrolling, Phase II
Updated: 12/31/1969
UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
North Star Lodge
mi
from
Yakima, WA
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Bixby Medical Center
mi
from
Adrian, MI
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Alaska Women's Cancer Care
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
AnMedical Health Cancer Center
mi
from
Anderson, SC
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Charles Health System
mi
from
Bend, OR
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Billings Clinic Cancer Center
mi
from
Billings, MT
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
McFarland Clinic PC-Boone
mi
from
Boone, IA
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Cox Cancer Center Branson
mi
from
Branson, MO
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Montefiore Medical Center-Einstein Campus
mi
from
Bronx, NY
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Francis Medical Center
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence Regional Cancer System-Centralia
mi
from
Centralia, WA
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Clackamas Radiation Oncology Center
mi
from
Clackamas, OR
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Center of Kansas, PA - Dodge City
mi
from
Dodge City, KS
Click here to add this to my saved trials